Synergistic Tissue Microablation System with AI, IoT, Blockchain, and Advanced Materials

Publication ID: 24-11857810_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Tissue Microablation System with AI, IoT, Blockchain, and Advanced Materials,” Published Technical Disclosure No. 24-11857810_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857810_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,810.

Summary of the Inventive Concept

A novel system and methods for tissue microablation that integrates AI, IoT, blockchain, and advanced materials to provide personalized, real-time, and optimized treatment protocols for various skin and tissue conditions.

Background and Problem Solved

The original patent described a system and methods for laser microablation using fractional treatment patterns. However, it had limitations in terms of treatment protocol optimization, patient data management, and thermal damage control. The new inventive concept addresses these limitations by incorporating AI, IoT, blockchain, and advanced materials to create a more powerful and efficient system.

Detailed Description of the Inventive Concept

The system comprises a laser unit, a laser emitting device, a scanning device, and an AI module that optimizes treatment protocols based on real-time analysis of tissue conditions and treatment efficacy. The system also utilizes blockchain technology to securely store and manage patient data, generating a unique fractional treatment pattern based on said data using machine learning algorithms. Additionally, the system incorporates IoT technology to monitor and adjust treatment parameters in real-time, and new materials with enhanced thermal conductivity to improve treatment efficiency and reduce thermal damage. The AI-powered computer vision module analyzes images of tissue during treatment, adjusting treatment parameters to achieve optimal treatment outcomes.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and advanced materials, which are not present in the original patent. The inventive step lies in the synergistic combination of these technologies to create a more powerful and efficient system for tissue microablation.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT protocols, blockchain platforms, or advanced materials. Variations may include the integration of additional technologies, such as robotics or nanotechnology, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical and cosmetic industries, particularly in the treatment of various skin and tissue conditions. The system's ability to provide personalized, real-time, and optimized treatment protocols makes it an attractive solution for clinicians and patients alike.

Original Patent Information

Patent NumberUS 11,857,810
TitleSystem and methods of tissue microablation using fractional treatment patterns
Assignee(s)LUMENIS BE LTD.